2020 Q1 Form 10-Q Financial Statement
#000156459020025275 Filed on May 14, 2020
Income Statement
| Concept | 2020 Q1 | 2019 Q4 | 2019 Q1 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $1.820M | $1.450M | $1.890M |
| YoY Change | -3.7% | -11.04% | 4.42% |
| % of Gross Profit | |||
| Research & Development | $1.541M | $1.763M | $4.055M |
| YoY Change | -62.0% | -15.28% | 237.64% |
| % of Gross Profit | |||
| Depreciation & Amortization | $60.00K | $60.00K | $70.00K |
| YoY Change | -14.29% | 0.0% | -22.22% |
| % of Gross Profit | |||
| Operating Expenses | $1.541M | $1.763M | $4.055M |
| YoY Change | -62.0% | -15.28% | 237.64% |
| Operating Profit | |||
| YoY Change | |||
| Interest Expense | $40.00K | $30.00K | $60.00K |
| YoY Change | -33.33% | -62.5% | 500.0% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $37.00K | $15.00K | $36.00K |
| YoY Change | 2.78% | -79.17% | -550.0% |
| Pretax Income | -$3.320M | -$3.190M | -$5.900M |
| YoY Change | -43.73% | -12.36% | 95.23% |
| Income Tax | |||
| % Of Pretax Income | |||
| Net Earnings | -$3.320M | -$3.194M | -$5.904M |
| YoY Change | -43.77% | -12.18% | 95.37% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$107.3K | -$5.800M | -$17.35M |
| COMMON SHARES | |||
| Basic Shares Outstanding | 31.35M | 6.721M | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2020 Q1 | 2019 Q4 | 2019 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $12.20M | $16.70M | $9.700M |
| YoY Change | 25.77% | 14.38% | 130.95% |
| Cash & Equivalents | $12.21M | $16.66M | $7.370M |
| Short-Term Investments | $2.300M | ||
| Other Short-Term Assets | $700.0K | $700.0K | $900.0K |
| YoY Change | -22.22% | -22.22% | 50.0% |
| Inventory | |||
| Prepaid Expenses | $662.0K | ||
| Receivables | $0.00 | $8.000K | |
| Other Receivables | $0.00 | $0.00 | |
| Total Short-Term Assets | $12.90M | $17.33M | $10.50M |
| YoY Change | 22.86% | 11.57% | 121.24% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $300.0K | $57.00K | $500.0K |
| YoY Change | -40.0% | 62.86% | 2677.78% |
| Goodwill | $1.034M | ||
| YoY Change | 0.0% | ||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $300.0K | $187.0K | $100.0K |
| YoY Change | 200.0% | 58.47% | -25.93% |
| Total Long-Term Assets | $3.700M | $3.744M | $4.000M |
| YoY Change | -7.5% | 5.55% | 6.55% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $12.90M | $17.33M | $10.50M |
| Total Long-Term Assets | $3.700M | $3.744M | $4.000M |
| Total Assets | $16.60M | $21.08M | $14.50M |
| YoY Change | 14.48% | 10.45% | 70.59% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $200.0K | $859.0K | $700.0K |
| YoY Change | -71.43% | 496.53% | 75.0% |
| Accrued Expenses | $1.400M | $2.000M | $3.300M |
| YoY Change | -57.58% | -35.48% | 73.68% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $1.500M | $2.869M | $4.000M |
| YoY Change | -62.5% | -12.26% | 73.91% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $100.0K | $200.0K | $300.0K |
| YoY Change | -66.67% | ||
| Total Long-Term Liabilities | $100.0K | $200.0K | $300.0K |
| YoY Change | -66.67% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $1.500M | $2.869M | $4.000M |
| Total Long-Term Liabilities | $100.0K | $200.0K | $300.0K |
| Total Liabilities | $1.700M | $3.028M | $4.300M |
| YoY Change | -60.47% | -7.74% | 85.5% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$49.02M | -$45.70M | |
| YoY Change | 80.07% | ||
| Common Stock | $64.01M | $63.75M | |
| YoY Change | 54.81% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $14.99M | $18.05M | $10.19M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $16.65M | $21.08M | $14.50M |
| YoY Change | 14.81% | 10.45% | 71.39% |
Cashflow Statement
| Concept | 2020 Q1 | 2019 Q4 | 2019 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$3.320M | -$3.194M | -$5.904M |
| YoY Change | -43.77% | -12.18% | 95.37% |
| Depreciation, Depletion And Amortization | $60.00K | $60.00K | $70.00K |
| YoY Change | -14.29% | 0.0% | -22.22% |
| Cash From Operating Activities | -$4.461M | -$3.420M | -$4.889M |
| YoY Change | -8.75% | -3.39% | 118.94% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $2.000K | $0.00 | $54.00K |
| YoY Change | -96.3% | -100.0% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | $2.740M | |
| YoY Change | -100.0% | 27300.0% | |
| Cash From Investing Activities | -$2.000K | $0.00 | $2.690M |
| YoY Change | -100.07% | -100.0% | 26800.0% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -47.00K | 12.71M | 0.000 |
| YoY Change | 153.69% | -100.0% | |
| NET CHANGE | |||
| Cash From Operating Activities | -4.461M | -3.420M | -4.889M |
| Cash From Investing Activities | -2.000K | 0.000 | 2.690M |
| Cash From Financing Activities | -47.00K | 12.71M | 0.000 |
| Net Change In Cash | -4.508M | 9.290M | -2.195M |
| YoY Change | 105.38% | -514.73% | 96.16% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$4.461M | -$3.420M | -$4.889M |
| Capital Expenditures | $2.000K | $0.00 | $54.00K |
| Free Cash Flow | -$4.463M | -$3.420M | -$4.943M |
| YoY Change | -9.71% | -3.12% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
63709000 | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
18050000 | |
| CY2020Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
3357000 | |
| CY2020Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
42000 | |
| CY2019Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
62000 | |
| CY2019Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-26000 | |
| CY2020Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-3320000 | |
| CY2019Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-5904000 | |
| CY2020Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
61000 | |
| CY2019Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
65000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-8000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-88000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
550000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-199000 | |
| CY2020Q1 | achv |
Increase Decrease In Accrued Clinical Liabilities
IncreaseDecreaseInAccruedClinicalLiabilities
|
184000 | |
| CY2019Q1 | achv |
Increase Decrease In Accrued Clinical Liabilities
IncreaseDecreaseInAccruedClinicalLiabilities
|
887000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-680000 | |
| CY2019Q1 | achv |
Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
|
-14000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4461000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-4889000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-47000 | |
| CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
54000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
20000 | |
| CY2019Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
2764000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-2000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
2690000 | |
| CY2020Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2000 | |
| CY2019Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
4000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-4508000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2195000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
16714000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
9565000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
12206000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
7370000 | |
| CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
302000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
15802000 | |
| CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
21078000 | |
| CY2020Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
159000 | |
| CY2019Q4 | us-gaap |
Liabilities
Liabilities
|
3028000 | |
| CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
41000 | |
| CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-45704000 | |
| CY2019Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
4000 | |
| CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
8000 | |
| CY2019Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
329000 | |
| CY2019Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
187000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
2087000 | |
| CY2019Q4 | us-gaap |
Goodwill
Goodwill
|
1034000 | |
| CY2019Q4 | us-gaap |
Assets
Assets
|
21078000 | |
| CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
859000 | |
| CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
304000 | |
| CY2019Q4 | achv |
Accrued Liabilities Clinical Current
AccruedLiabilitiesClinicalCurrent
|
387000 | |
| CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1116000 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
203000 | |
| CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2869000 | |
| CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2020Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
150000000 | |
| CY2020Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
31352764 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
29485178 | |
| CY2020Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
31352764 | |
| CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
29485178 | |
| CY2020Q1 | achv |
Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
|
4000 | |
| CY2020Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
63962000 | |
| CY2020Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
4000 | |
| CY2020Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
43000 | |
| CY2020Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-49024000 | |
| CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
14985000 | |
| CY2020Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
16647000 | |
| CY2019Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
5940000 | |
| CY2020Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | |
| CY2019Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
|
133 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1497600 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
10189000 | |
| CY2020Q1 | achv |
Working Capital Balance
WorkingCapitalBalance
|
11400000 | |
| CY2015Q2 | us-gaap |
Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
|
3100000 | |
| CY2015Q2 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P14Y | |
| CY2020Q1 | achv |
Finite Lived Intangible Assets Amortization Expense After Year Fourth
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFourth
|
1195000 | |
| CY2020Q1 | us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | |
| CY2020Q1 | us-gaap |
Cash
Cash
|
550000 | |
| CY2020Q1 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
50000 | |
| CY2020Q1 | achv |
Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
|
P90D | |
| CY2020Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
| CY2020Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2020Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
|
0 | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1010583 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
18757 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2489426 | |
| CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
10.05 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.56 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
4.33 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.38 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0151 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0256 | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.00 | |
| CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y7D | |
| CY2019Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y7D | |
| CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.0406 | |
| CY2019Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.9372 | |
| CY2020Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
2200000 | |
| CY2020Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
29615486 | |
| CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
5038584 | |
| CY2020Q1 | achv |
Number Of Warrants Exercised
NumberOfWarrantsExercised
|
0 | |
| CY2019Q1 | achv |
Number Of Warrants Exercised
NumberOfWarrantsExercised
|
0 | |
| CY2020Q1 | us-gaap |
Contractual Obligation
ContractualObligation
|
308000 | |
| CY2020Q1 | us-gaap |
Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
|
156000 | |
| CY2020Q1 | us-gaap |
Contractual Obligation Due In Second And Third Year
ContractualObligationDueInSecondAndThirdYear
|
147000 | |
| CY2020Q1 | us-gaap |
Contractual Obligation Due In Fourth And Fifth Year
ContractualObligationDueInFourthAndFifthYear
|
5000 | |
| CY2020Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
44000 | |
| CY2019Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
50000 | |
| CY2019Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
455000 | |
| CY2020Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y11M26D | |
| CY2020Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0990 | |
| CY2019Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0990 | |
| CY2020Q1 | us-gaap |
Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
|
0 | |
| CY2020Q1 | achv |
Indemnification Expense
IndemnificationExpense
|
0 |
